Prospeo
Hero Section BackgroundHero Section Background
Repertoire Immune Medicines

Repertoire Immune Medicines Email Formats

Biotechnology ResearchFlag of USCambridge, Massachusetts, United States51-100 Employees

Repertoire Immune Medicines Email Formats

Repertoire Immune Medicines uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@repertoire.com), used 91.3% of the time.

FormatExamplePercentage
{first name}{last name}
johndoe@repertoire.com
91.3%
{first initial}{last name}
jdoe@repertoire.com
8.7%

Key Contacts at Repertoire Immune Medicines

Flag of US

Grace Yan

Associate Director, Financial Planning & Analysis

Flag of US

Ewen Cameron

Co-Founder

Flag of US

John Abel

Senior Director, Computational Science And Artificial Intelligence

Flag of US

Jessica Copertino

Associate Director, Lab Operations & Facilities Management

Flag of US

Catarina Nogueira

Director

Flag of US

Prashant Shambharkar

Associate Director | Team Leader

Flag of US

Thomas Malia

Director, Protein Sciences

Flag of US

Elizabeth Parker

Director Clinical Operations

Flag of US

George Regas

Associate Director Of Information Technology

Flag of US

Ming Proschitsky

Associate Director

Company overview

HeadquartersCambridge, Massachusetts, United States
Phone number+16178633650
Website
NAICS541714
SIC873
Founded2020
Employees51-100
Socials

About Repertoire Immune Medicines

Repertoire Immune Medicines is a biotechnology company dedicated to creating treatments for diseases based on the power of the human T cell repertoire to eliminate cancer cells, target pathogens, and regulate immune function in autoimmune disease. The company’s proprietary DECODE™ platform provides a comprehensive understanding of the interactions between T cell receptors and their antigens in disease. DECODE uniquely elucidates the entire immune synapse, including the T-cell receptor-epitope pairs that defines it, the HLA context, and the T cell phenotype. This capability enables the creation of new and potentially transformative classes of immune-based medicines. Repertoire believes the ability to decipher these interactions represents one of the greatest opportunities for innovation in medical science. The company is utilizing the discoveries from DECODE to design and develop novel immune therapies for multiple therapeutic areas, such as autoimmune diseases, infectious diseases, and cancer. The team operates from sites in Cambridge, Massachusetts and Zurich. To learn more about Repertoire, please visit www.repertoire.com.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry
Director
Senior

Employees by Department

Repertoire Immune Medicines has 41 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Repertoire Immune Medicines's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2021-05-135$189,000,000

Funding Insights

$189,000,000

Total funding amount

$189,000,000

Most recent funding amount

1

Number of funding rounds

Repertoire Immune Medicines Tech Stack

Discover the technologies and tools that power Repertoire Immune Medicines's digital infrastructure, from frameworks to analytics platforms.

Nginx

Nginx

Reverse proxies

Apple iCloud Mail

Apple iCloud Mail

Webmail

PHP

PHP

Programming languages

Open Graph

Open Graph

Miscellaneous

Yii

Yii

Web frameworks

Craft CMS

Craft CMS

CMS

Microsoft 365

Microsoft 365

Email

Frequently asked questions

Repertoire Immune Medicines is located in Cambridge, Massachusetts, US.
You can reach Repertoire Immune Medicines at +16178633650.
Repertoire Immune Medicines was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.
Repertoire Immune Medicines has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.
Repertoire Immune Medicines has raised a total of $189,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles